Mithra Pharmaceuticals: MITHRA TO INITIATE PK STUDY FOR ESTELLE®
May 12, 2017 01:30 ET
|
Mithra Pharmaceuticals
PRESS RELEASE Mithra to initiate pk study FOR ESTELLE® First step toward bringing Estelle® to the Japanese...
Mithra Pharmaceuticals: MITHRA REPORTS 2016 ANNUAL RESULTS
March 02, 2017 01:30 ET
|
Mithra Pharmaceuticals
Mithra reports 2016 annual results Significant operational progress across our transformational E4 (Estetrol) programs and our complex therapeutic solutions positions Mithra for long-term...
Mithra Pharmaceuticals: Mithra Signs a Binding Term Sheet with the Japanese Leader in Women's Health Fuji Pharma to Commercialize Donesta® in Japan and ASEAN[1]
March 01, 2017 13:50 ET
|
Mithra Pharmaceuticals
PRESS RELEASE Mithra Signs a Binding Term Sheet with the Japanese Leader in Women's Health Fuji Pharma to Commercialize Donesta® in Japan and ASEAN[1] Mithra signs a binding...
Mithra Pharmaceuticals: AGREES EXCLUSIVE LONG-TERM LICENSE AND SUPPLY AGREEMENT WITH MAYNE PHARMA TO COMMERCIALIZE MYRING(TM) IN THE US
February 28, 2017 07:00 ET
|
Mithra Pharmaceuticals
PRESS RELEASE Mithra agrees Exclusive LONG-TERM license and supply agreement with Mayne Pharma to commercialize Myring(TM) in the US Mithra grants its first exclusive license...
Mithra Pharmaceuticals: AGREES EXCLUSIVE LONG-TERM LICENSE AND SUPPLY AGREEMENT WITH MAYNE PHARMA TO COMMERCIALIZE MYRING(TM) IN THE US
February 28, 2017 01:00 ET
|
Mithra Pharmaceuticals
PRESS RELEASE Mithra agrees Exclusive LONG-TERM license and supply agreement with Mayne Pharma to commercialize Myring(TM) in the US Mithra grants its first exclusive license...
Mithra Pharmaceuticals: MITHRA GRANTED EUR 1.9 MILLION IN NON-DILUTIVE FUNDING
February 13, 2017 06:00 ET
|
Mithra Pharmaceuticals
PRESS RELEASE MITHRA granted eur 1.9 million in non-dilutive funding Non-dilutive funding granted by the Walloon region Funding to support Estetrol (E4) and complex therapeutics solutions...
MITHRA COMPLETES RECRUITMENT FOR EUROPEAN PHASE III ESTELLE® STUDY
February 07, 2017 01:30 ET
|
Mithra Pharmaceuticals
PRESS RELEASE MITHRA COMPLETES RECRUITMENT FOR European phase iii estelle® study Liège, Belgium, 07 February 2017 - Mithra Pharmaceuticals (Euronext Brussels: MITRA), a company focused on...
Mithra Pharmaceuticals: MITHRA STRENGTHENS POSITION IN THE BELGIAN CONTRACEPTION MARKET
January 31, 2017 01:30 ET
|
Mithra Pharmaceuticals
PRESS RELEASE Mithra Strengthens Position in the Belgian Contraception Market Mithra builds on leading position in Belgian contraceptive market Mithra achieves significant increase in 2016...
Mithra Pharmaceuticals: Mithra plans to submit Myring for US and EU approval in Q2 2017
January 24, 2017 01:30 ET
|
Mithra Pharmaceuticals
PRESS RELEASE Mithra plans to submit myring for us and eu approval in q2 2017 Planned submissions follow successful trials demonstrating bioequivalence to NuvaRing® Liège, Belgium, 24...
MITHRA ANNOUNCES US PATENT ALLOWANCE FOR THE USE OF ESTETROL AS EMERGENCY CONTRACEPTIVE
January 18, 2017 01:30 ET
|
Mithra Pharmaceuticals
PRESS RELEASE MITHRA ANNOUNCES US PATENT ALLOWANCE FOR THE USE OF ESTETROL AS EMERGENCY CONTRACEPTIVE Liège, Belgium, 18 January 2017 - Mithra Pharmaceuticals (Euronext Brussels: MITRA), a...